Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
13.97
-0.46 (-3.19%)
At close: Feb 27, 2026, 4:00 PM EST
14.05
+0.08 (0.57%)
After-hours: Feb 27, 2026, 7:58 PM EST

TNXP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
179622422177129
Market Cap Growth
178.01%160.94%5.35%-87.36%37.35%1226.92%
Enterprise Value
-114218-117-475
Last Close Price
13.9732.981289.607796.00228928.00432000.00
PS Ratio
17.356.113.04---
PB Ratio
0.610.440.220.110.811.47
P/TBV Ratio
0.770.440.250.110.811.48
EV/Sales Ratio
-4.172.30---
Debt / Equity Ratio
0.000.060.090.000.000.02
Net Debt / Equity Ratio
-0.82-0.65-0.14-0.58-0.81-0.86
Net Debt / EBITDA Ratio
1.951.220.131.081.931.50
Net Debt / FCF Ratio
2.491.490.140.821.601.33
Asset Turnover
0.060.060.04---
Inventory Turnover
0.970.69----
Quick Ratio
9.295.821.336.618.237.85
Current Ratio
9.896.502.537.198.718.96
Return on Equity (ROE)
-64.99%-106.12%-74.61%-51.76%-60.25%-103.98%
Return on Assets (ROA)
-35.94%-30.62%-38.93%-30.03%-34.03%-56.00%
Return on Capital Employed (ROCE)
-43.20%-53.80%-87.30%-54.00%-42.10%-57.20%
Earnings Yield
-55.51%-210.97%-493.86%-491.58%-52.02%-39.07%
FCF Yield
-42.70%-99.04%-465.24%-652.06%-62.49%-44.23%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q